The cytology fixatives market is projected to grow from USD 402.4 million in 2025 to USD 607.2 million by 2035 at a 4.2% CAGR. Liquid-based cytology fixatives dominate with a 41.2% market share. Cancer screening applications lead to 38%, driven by increasing cancer prevalence and focus on early diagnosis.